Asia Pacific Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026
The Asia Pacific Sclerotherapy Market would witness market growth of 9.3% CAGR during the forecast period (2020-2026).
The sclerotherapy is usually used to treat spider veins, haemorrhoids, and smaller varicose veins in adults. In Sclerotherapy, a very fine and thin injection needle is used to inject solution in order to treat small varicose veins in the legs, improve the appearance of spider veins, and get rid of related symptoms like burning, aching, swelling and cramping. Dermatologists have played an important role in the advancement of new safe, and non-invasive technologies that can be use in the treatment of both larger varicose veins, and cosmetic telangiectasias and procedure has become a medical significance. The major advancements have been made in sclerosing solutions, and endovascular RF and laser procedures and they have brought a revolution in the healthcare industry.
Varicose veins and telangiectasias if left untreated, they can cause severe health problems like deep vein clots, skin ulcers, chronic pain, and coronary ailments. According to NCBI, more than 20.0% of all adults suffer from varicose veins at some point or the other time in their lives and the occurrence is higher among the elderly population and women. These factors are likely to lift the market growth. Though, the side effects of this procedure including hyperpigmentation, scarring, matting, and allergic reactions in some patients are expected to hinder the market growth.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the Study
Market Segmentation:
By Agent
The sclerotherapy is usually used to treat spider veins, haemorrhoids, and smaller varicose veins in adults. In Sclerotherapy, a very fine and thin injection needle is used to inject solution in order to treat small varicose veins in the legs, improve the appearance of spider veins, and get rid of related symptoms like burning, aching, swelling and cramping. Dermatologists have played an important role in the advancement of new safe, and non-invasive technologies that can be use in the treatment of both larger varicose veins, and cosmetic telangiectasias and procedure has become a medical significance. The major advancements have been made in sclerosing solutions, and endovascular RF and laser procedures and they have brought a revolution in the healthcare industry.
Varicose veins and telangiectasias if left untreated, they can cause severe health problems like deep vein clots, skin ulcers, chronic pain, and coronary ailments. According to NCBI, more than 20.0% of all adults suffer from varicose veins at some point or the other time in their lives and the occurrence is higher among the elderly population and women. These factors are likely to lift the market growth. Though, the side effects of this procedure including hyperpigmentation, scarring, matting, and allergic reactions in some patients are expected to hinder the market growth.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the Study
Market Segmentation:
By Agent
- Detergents
- Osmotic Agents
- Chemical Irritants
- Liquid Sclerotherapy
- Ultrasound Sclerotherapy
- Foam Sclerotherapy
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Boston Scientific Corporation
- Perrigo Company PLC (Omega Pharmaceuticals)
- Cook Medical, Inc. (Cook Group)
- Chemische Fabrik Kreussler & Co. GmbH
- LGM Pharma, LLC
- Troikaa Pharmaceuticals Limited
- Tianyu Chang’an Group
- Endo-Flex GmbH (Meditek Systems)
- Merz Pharma GmbH & Co. KGaA
- MTW-Endoskopie W. Haag KG
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Sclerotherapy Market, by Agent
1.4.2 Asia Pacific Sclerotherapy Market, by Type
1.4.3 Asia Pacific Sclerotherapy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Market Composition and Scenario
2.3 Key Factors Impacting the Market
2.3.1 Market Drivers
2.3.2 Market Restraints
CHAPTER 3. ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT
3.1 Asia Pacific Detergents Market by Country
3.2 Asia Pacific Osmotic Agents Market by Country
3.3 Asia Pacific Chemical Irritants Market by Country
CHAPTER 4. ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE
4.1 Asia Pacific Liquid Sclerotherapy Market by Country
4.2 Asia Pacific Ultrasound Sclerotherapy Market by Country
4.3 Asia Pacific Other Type Market by Country
CHAPTER 5. ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY
5.1 China Sclerotherapy Market
5.1.1 China Sclerotherapy Market by Agent
5.1.2 China Sclerotherapy Market by Type
5.2 Japan Sclerotherapy Market
5.2.1 Japan Sclerotherapy Market by Agent
5.2.2 Japan Sclerotherapy Market by Type
5.3 India Sclerotherapy Market
5.3.1 India Sclerotherapy Market by Agent
5.3.2 India Sclerotherapy Market by Type
5.4 South Korea Sclerotherapy Market
5.4.1 South Korea Sclerotherapy Market by Agent
5.4.2 South Korea Sclerotherapy Market by Type
5.5 Singapore Sclerotherapy Market
5.5.1 Singapore Sclerotherapy Market by Agent
5.5.2 Singapore Sclerotherapy Market by Type
5.6 Malaysia Sclerotherapy Market
5.6.1 Malaysia Sclerotherapy Market by Agent
5.6.2 Malaysia Sclerotherapy Market by Type
5.7 Rest of Asia Pacific Sclerotherapy Market
5.7.1 Rest of Asia Pacific Sclerotherapy Market by Agent
5.7.2 Rest of Asia Pacific Sclerotherapy Market by Type
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Sclerotherapy Market, by Agent
1.4.2 Asia Pacific Sclerotherapy Market, by Type
1.4.3 Asia Pacific Sclerotherapy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Market Composition and Scenario
2.3 Key Factors Impacting the Market
2.3.1 Market Drivers
2.3.2 Market Restraints
CHAPTER 3. ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT
3.1 Asia Pacific Detergents Market by Country
3.2 Asia Pacific Osmotic Agents Market by Country
3.3 Asia Pacific Chemical Irritants Market by Country
CHAPTER 4. ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE
4.1 Asia Pacific Liquid Sclerotherapy Market by Country
4.2 Asia Pacific Ultrasound Sclerotherapy Market by Country
4.3 Asia Pacific Other Type Market by Country
CHAPTER 5. ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY
5.1 China Sclerotherapy Market
5.1.1 China Sclerotherapy Market by Agent
5.1.2 China Sclerotherapy Market by Type
5.2 Japan Sclerotherapy Market
5.2.1 Japan Sclerotherapy Market by Agent
5.2.2 Japan Sclerotherapy Market by Type
5.3 India Sclerotherapy Market
5.3.1 India Sclerotherapy Market by Agent
5.3.2 India Sclerotherapy Market by Type
5.4 South Korea Sclerotherapy Market
5.4.1 South Korea Sclerotherapy Market by Agent
5.4.2 South Korea Sclerotherapy Market by Type
5.5 Singapore Sclerotherapy Market
5.5.1 Singapore Sclerotherapy Market by Agent
5.5.2 Singapore Sclerotherapy Market by Type
5.6 Malaysia Sclerotherapy Market
5.6.1 Malaysia Sclerotherapy Market by Agent
5.6.2 Malaysia Sclerotherapy Market by Type
5.7 Rest of Asia Pacific Sclerotherapy Market
5.7.1 Rest of Asia Pacific Sclerotherapy Market by Agent
5.7.2 Rest of Asia Pacific Sclerotherapy Market by Type
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 CHINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 CHINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 CHINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 CHINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 CHINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 26 CHINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 27 JAPAN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 28 JAPAN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 29 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 30 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 31 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 INDIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 34 INDIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 35 INDIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 36 INDIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 37 INDIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 38 INDIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 39 SOUTH KOREA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 40 SOUTH KOREA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 41 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 42 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 43 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 44 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 45 SINGAPORE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SINGAPORE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 48 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 49 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 50 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 51 MALAYSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 52 MALAYSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 53 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 54 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 55 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 56 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 57 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 62 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 64 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 65 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 66 KEY INFORMATION – CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 67 KEY INFORMATION – LGM PHARMA, LLC
TABLE 68 KEY INFORMATION – TROIKAA PHARMACEUTICALS LIMITED
TABLE 69 KEY INFORMATION – TIANYU CHANG’AN GROUP
TABLE 70 KEY INFORMATION –ENDO-FLEX GMBH
TABLE 71 KEY INFORMATION – MERZ PHARMA GMBH & CO. KGAA
TABLE 72 KEY INFORMATION – MTW-ENDOSKOPIE W. HAAG KG
TABLE 1 ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 CHINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 CHINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 CHINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 CHINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 CHINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 26 CHINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 27 JAPAN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 28 JAPAN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 29 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 30 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 31 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 INDIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 34 INDIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 35 INDIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 36 INDIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 37 INDIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 38 INDIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 39 SOUTH KOREA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 40 SOUTH KOREA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 41 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 42 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 43 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 44 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 45 SINGAPORE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SINGAPORE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 48 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 49 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 50 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 51 MALAYSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 52 MALAYSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 53 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 54 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 55 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 56 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 57 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 62 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 64 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 65 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 66 KEY INFORMATION – CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 67 KEY INFORMATION – LGM PHARMA, LLC
TABLE 68 KEY INFORMATION – TROIKAA PHARMACEUTICALS LIMITED
TABLE 69 KEY INFORMATION – TIANYU CHANG’AN GROUP
TABLE 70 KEY INFORMATION –ENDO-FLEX GMBH
TABLE 71 KEY INFORMATION – MERZ PHARMA GMBH & CO. KGAA
TABLE 72 KEY INFORMATION – MTW-ENDOSKOPIE W. HAAG KG
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
